Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

SQI Diagnostics Inc. (V:SQD)

Business Focus: Advanced Medical Equipment & Technology

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for SQD within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jun 15, 2021 15:00 ET
SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders
TORONTO, June 15, 2021 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announces that certain insiders of the Company, who are control persons (the "Control Persons"), have exercised 19,687,504 common share (each, a "Share") purchase warrants of the Company (the "Insider Warrants") for aggregate gross proceeds of approximately $3.9 million. Of the Insider Warrants exercised, 19,687,504 Insider Warrants were
Read full article
Jun 15, 2021 15:00 ET
SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders
TORONTO, June 15, 2021 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics today announces that certain insiders of the Company, who are control persons (the "Control Persons"), have exercised 19,687,504 common share (each, a "Share") purchase warrants of the Company (the "Insider Warrants") for aggregate gross proceeds of approximately $3.9 million. Of the Insider Warrants exercised, 19,687,504 Insider Warrant
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.07
--
--
Price to Sales - TTM
86.96
24.83
14.10
Price to Book - most recent quarter
34.50
4.59
3.89
Price to Cash Flow per share - TTM
--
50.70
19.93
Price to Free Cash Flow per share - TTM
--
74.78
38.48
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
May 31, 2021323,523259,240
May 15, 202164,28333,424
Apr 30, 202130,85911,930
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates. Its Ig_plex microarrays have the ability to discriminate between individual isotypes of antibodies and antigens and proteins within a single well of a microarray. Its Ig_plex CHEX technology provides multiple in-microarray checks. It has three areas of focus: Testing for the drug development industry, Animal health testing, Human disease testing or deoxyribonucleic acid (DNA) diagnostic testing. In drug development testing, SQI provides technology and equipment for blood testing in clinical trials and pre-clinical research for developing various drugs. It applies its multiplexing technology to diagnostic tests used for customers in the animal health segment.

See business summary

 

Twitter

Search (past week) for $SQD.CA SQD.V

  • No tweets found